Presentation Information
[2P-940]Elucidation of Malignant Transformation Mechanisms and Therapeutic Compound Screening Using Patient-Derived iPS Cells in Neurofibromatosis Type 1
○Taro Osawa1, Eiji Nakata2, Aoba Nakajima1, Tatsunori Osone1, Shigeo Otake1, Mashu Futagawa3, Tomoka Takao1, Akira Hirasawa3, Toshifumi Ozaki 2, Takeshi Takarada1 (1. Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2. Department Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 3. Department of Clinical Genomic Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences)
Password required to view
Please enter the password printed on your name card.
Online registrants can download your name card from the account page once payment has been successfully processed.
Online registrants can download your name card from the account page once payment has been successfully processed.
Comment
To browse or post comments, you must log in.Log in